If you are on a GLP-1 medication and you have a procedure on the calendar, this one detail can change your day: the surgery center may cancel or delay you if the anesthesia team is not told in advance. Here is what is actually going on and how to stay ahead of it.
Why anesthesia teams started asking about GLP-1s
Medications in the GLP-1 class (semaglutide is one) and the dual GIP/GLP-1 class (tirzepatide is one) work in part by slowing how fast the stomach empties [1][2]. That delayed gastric emptying is part of why these drugs help with appetite and fullness. It is also why anesthesiologists pay attention to them.
General anesthesia and deep sedation relax the reflexes that normally keep stomach contents out of your airway. If the stomach still holds food or liquid when you go under, there is a risk that material can come back up and be inhaled into the lungs. That event is called pulmonary aspiration, and it is one of the specific safety concerns anesthesia teams manage before any procedure [3].
The usual defense is straightforward: fasting before surgery so the stomach is empty. The concern with GLP-1 medications is that the stomach may not empty on the normal schedule, so a person who followed standard fasting instructions could still have retained stomach contents [3][4]. That is the whole reason your care team wants to know.
What the professional guidance actually says
This is an evolving area, and the guidance has shifted as more data has come in, so it is worth being precise.
In 2023, the American Society of Anesthesiologists issued guidance recommending that GLP-1 medications be considered before elective procedures, including holding them ahead of surgery and treating patients as higher aspiration risk in some cases [4]. In 2024, a multi-society clinical practice statement (including the American Society of Anesthesiologists and gastroenterology and endoscopy societies) took a more individualized approach: rather than automatically stopping the medication for everyone, it emphasized assessing each patient's risk and, in some situations, using measures like a longer clear-liquid period or point-of-care ultrasound to check whether the stomach is empty [5].
The practical takeaway for you is not to self-manage this. It is that both the provider who prescribes your medication and the team performing your procedure need to be looped in early enough to make a plan together.
The delayed-emptying mechanism, in plain terms
GLP-1 is a hormone your gut releases after you eat. Medications in this class mimic it. Among other effects, activating GLP-1 receptors slows gastric emptying, meaning food and liquid move out of the stomach more slowly than usual [1][2]. This effect tends to be strongest earlier in treatment and can lessen over time for some people, but it does not disappear on a fixed, predictable date, which is part of why a blanket rule is hard to write and why individual assessment matters [2][5].
This mechanism is also behind common, well-documented side effects like nausea and feeling full quickly, which the FDA prescribing information for these molecules lists among the most frequent gastrointestinal effects [1].
Source: [1] FDA Prescribing Information: semaglutide injection (label via DailyMed/FDA), [2] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gastric Emptying (PubMed)
What this means for a busy calendar
If you run a business and schedule procedures around your work, the failure mode here is a same-day cancellation because nobody knew you were on a GLP-1. That costs you the day, the rescheduling, and the momentum. Avoiding it is mostly about communication and timing, not complexity.
A few things worth knowing:
- This applies to more than major surgery. Dental sedation, colonoscopy and other endoscopy, and outpatient procedures under sedation all involve the same airway and aspiration considerations [3][5].
- "Elective" is the key word. For urgent or emergency procedures, the team cannot always wait, so they manage the risk in real time. That is another reason to disclose the medication no matter what.
- The decision about whether to pause a medication, for how long, or to adjust your pre-procedure fasting belongs to your prescriber and the anesthesia team, together. It is not a do-it-yourself calculation.
The coordination an independent provider walks you through
Think of this as a short checklist that the professionals handle, with your job being early, honest disclosure.
Before you book, or as soon as you can
1. Tell the provider group that prescribed your GLP-1 that you have a procedure scheduled, and share the date. An independent provider can review your specific situation, your medication, and how long you have been on it.
2. Tell the surgeon, proceduralist, or dentist that you are on a GLP-1 or GIP/GLP-1 medication. Use the generic name (for example, semaglutide or tirzepatide), not a brand.
3. Make sure the anesthesia team specifically gets this information. It sometimes does not travel automatically between offices.
Questions your care teams may work through
- Whether the medication should be paused before the procedure, and if so, the timing they choose for you [4][5].
- Whether your fasting instructions should be modified, such as a longer period of clear liquids only [5].
- Whether they want to check gastric contents with ultrasound before proceeding in higher-risk cases [5].
- How to handle restarting the medication afterward.
Because these medications are typically taken on a weekly schedule, the timing conversation is best had early, not the night before. That is the single most useful thing you can do: give everyone runway.
Source: [4] American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients on GLP-1 Receptor Agonists, [5] Multisociety Clinical Practice Guidance for the Safe Use of GLP-1 Receptor Agonists in the Perioperative Period
A note on compounded medications
Some people take compounded versions of these molecules. If that is your situation, tell your care teams exactly what you are taking, since the concentration and formulation can differ. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
This article is educational and is not medical advice. It is not a recommendation to start, stop, pause, or change any medication. Decisions about your medication and your procedure should be made by the licensed professionals caring for you.
Where Velri fits
Velri is a technology and coordination company, not a medical practice. Velri does not provide medical care and employs no physicians. Care is delivered by independent, physician-led Provider Groups, and any medication is dispensed by independent, licensed pharmacies.
What Velri can coordinate is the logistics that make situations like this less stressful: helping arrange lab work, connecting you with a visit with an independent provider who can review your history and your current medications, and, if a provider decides a prescription is appropriate, coordinating with a licensed pharmacy. A prescription is never guaranteed; that decision rests solely with an independent licensed provider. If you have a procedure coming up, the Velri clinical review process is a place to raise it early so an independent provider can help you think through the coordination with your surgical or dental team. Coverage currently starts in Nevada, with more states rolling out over time.
